JP2013543117A5 - - Google Patents

Download PDF

Info

Publication number
JP2013543117A5
JP2013543117A5 JP2013530750A JP2013530750A JP2013543117A5 JP 2013543117 A5 JP2013543117 A5 JP 2013543117A5 JP 2013530750 A JP2013530750 A JP 2013530750A JP 2013530750 A JP2013530750 A JP 2013530750A JP 2013543117 A5 JP2013543117 A5 JP 2013543117A5
Authority
JP
Japan
Prior art keywords
antibody
sample
epitope
cancer
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013530750A
Other languages
English (en)
Japanese (ja)
Other versions
JP5893037B2 (ja
JP2013543117A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/067092 external-priority patent/WO2012042009A1/en
Publication of JP2013543117A publication Critical patent/JP2013543117A/ja
Publication of JP2013543117A5 publication Critical patent/JP2013543117A5/ja
Application granted granted Critical
Publication of JP5893037B2 publication Critical patent/JP5893037B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013530750A 2010-09-30 2011-09-30 Brafv600eに特異的に結合する抗体を使用する癌の診断のための手段及び方法 Active JP5893037B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38815810P 2010-09-30 2010-09-30
US61/388,158 2010-09-30
US201161503950P 2011-07-01 2011-07-01
US61/503,950 2011-07-01
PCT/EP2011/067092 WO2012042009A1 (en) 2010-09-30 2011-09-30 Means and methods for diagnosing cancer using an antibody which specifically binds to braf v600e

Publications (3)

Publication Number Publication Date
JP2013543117A JP2013543117A (ja) 2013-11-28
JP2013543117A5 true JP2013543117A5 (https=) 2015-10-01
JP5893037B2 JP5893037B2 (ja) 2016-03-23

Family

ID=44789447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013530750A Active JP5893037B2 (ja) 2010-09-30 2011-09-30 Brafv600eに特異的に結合する抗体を使用する癌の診断のための手段及び方法

Country Status (9)

Country Link
US (1) US9297812B2 (https=)
EP (1) EP2622348B1 (https=)
JP (1) JP5893037B2 (https=)
CN (1) CN103403550B (https=)
AU (1) AU2011310096B2 (https=)
CA (1) CA2813098C (https=)
DK (1) DK2622348T3 (https=)
ES (1) ES2554678T3 (https=)
WO (1) WO2012042009A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103172744B (zh) * 2012-09-28 2016-01-13 武汉纽斯特生物技术有限公司 特异性识别B-Raf突变蛋白的单克隆抗体、制备方法及其应用
JP6485854B2 (ja) * 2014-09-24 2019-03-20 国立研究開発法人国立循環器病研究センター 抗変異型プロテインs抗体、該抗体を含む診断用組成物、変異型ヒトプロテインsの検出方法および該抗体を含むキット
ES2928773T3 (es) 2017-01-17 2022-11-22 Heparegenix Gmbh Inhibidores de proteína cinasas para fomentar la regeneración hepática o reducir o prevenir la muerte de hepatocitos
WO2019004703A1 (ko) * 2017-06-29 2019-01-03 한국과학기술원 신경절 교세포종 및 이와 관련된 질환의 진단, 예방, 또는 치료용 조성물
CN110183535A (zh) * 2018-12-17 2019-08-30 南京基诺米医疗科技有限公司 鼠抗人braf v600e突变蛋白单克隆抗体制备及其免疫组化用途
CN111285935B (zh) * 2020-05-13 2020-09-11 方达医药技术(上海)有限公司 特异性检测braf基因突变的抗体及其在制备癌症检测试剂盒中的用途
AU2021378815A1 (en) * 2020-11-16 2023-06-29 Agilent Technologies, Inc. Chimeric anti-human braf v600e antibodies and methods for making and using them
WO2024090265A1 (ja) * 2022-10-28 2024-05-02 株式会社biomy 情報処理装置、情報処理方法及びプログラム

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6735531B2 (en) * 1996-10-07 2004-05-11 Lab Vision Corporation Method and apparatus for automatic tissue staining
AU2003286447A1 (en) * 2003-10-16 2004-06-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Treatments for inhibiting development and progression of nevi and melanoma having braf mutations
WO2007002811A2 (en) * 2005-06-29 2007-01-04 The Wistar Institute Of Anatomy And Biology Methods and compositions for treating melanoma
US8034792B2 (en) * 2007-09-11 2011-10-11 University Of Massachusetts Insulin-like growth factor binding protein 7 for treatment of cancer
CA2639416C (en) * 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2013543117A5 (https=)
JP2015533788A5 (https=)
US9846160B2 (en) Ganglioside GD2 as a marker and target on cancer stem cells
JP2020522261A5 (https=)
WO2012141844A3 (en) Methods predicting risk of an adverse clinical outcome
WO2022082073A2 (en) Compositions and methods for muc18 targeting
JP2015517982A5 (https=)
HUE030578T2 (en) Antibody recognising human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation
JP2013544493A5 (https=)
CN102251013A (zh) 一个识别肿瘤起始细胞的抗体和抗原及其应用
IL223874A (en) A new antibody for the diagnosis and / or prognosis of cancer
TW201529603A (zh) α-烯醇化酶特異性抗體及其於癌症治療之應用
Gong et al. Loss of lamin A but not lamin C expression in epithelial ovarian cancer cells is associated with metastasis and poor prognosis
JP2020037571A (ja) Tmcc3の阻害による、癌を抑制するための方法
JP2013505938A5 (https=)
US11009507B2 (en) Methods and diagnostics for cancer detection and treatment monitoring
EP3935391A1 (en) New biomarkers and biotargets in renal cell carcinoma
CN114929274B (zh) 琥珀酸作为用于癌症诊断和治疗的生物标记的用途
WO2019066617A2 (ko) 항 c-met 항체 및 이의 용도
US20160176936A1 (en) Mps peptides and use thereof
US10584387B2 (en) Detection of hepatitis delta virus (HDV) for the diagnosis and treatment of Sjögren's syndrome and lymphoma
JP2008535855A5 (https=)
JP2012515893A5 (https=)
JP2012521745A5 (https=)
WO2012141792A3 (en) Adiponectin receptor c-terminal fragments (ctf)-immunoglobulin